B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

LOXL4

MOLECULAR TARGET

lysyl oxidase like 4

UniProt: Q96JB6NCBI Gene: 841713 compounds

LOXL4 (lysyl oxidase like 4) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting LOXL4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1thiram2.4811
2pyrithione1.795
3Disulfiram0.691

About LOXL4 as a Drug Target

LOXL4 (lysyl oxidase like 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented LOXL4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

LOXL4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.